Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

Rhea-AI Summary

Bioventus Inc. (BVS) announced its financial results for the fourth quarter of fiscal year 2022 will be reported on March 30, 2023, before market opens. A conference call will follow at 8:30 a.m. ET to discuss the results and provide a business update. Investors can participate by dialing 1-833-636-0497 domestically or +1-412-902-4241 internationally. The call will be webcasted live and archived on the company’s Investor Relations website, available for replay until March 29, 2024. Bioventus focuses on innovations that promote active healing, showcasing its commitment to high-quality healthcare products.

Positive

• Scheduled financial report expected on March 30, 2023, indicating transparency.
• Live webcast of earnings call enhances investor accessibility.

Negative

• None.

DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2022 before the market opens on Thursday, March 30, 2023. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 29, 2024.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com

FAQ

When will Bioventus report its financial results for Q4 2022?

Bioventus will report its financial results for the fourth quarter of fiscal year 2022 on March 30, 2023.

What time is the Bioventus conference call scheduled for after the Q4 2022 earnings report?

The conference call is scheduled for 8:30 a.m. Eastern Time on March 30, 2023.

How can I participate in the Bioventus earnings call?

You can participate in the Bioventus earnings call by dialing 1-833-636-0497 for domestic calls or +1-412-902-4241 for international calls.

Where can I find the webcast of the Bioventus earnings call?

The webcast will be available on the 'Investor Relations' section of Bioventus's website.

How long will the Bioventus earnings call replay be available?

The earnings call replay will be available until March 29, 2024.